Title

Transcatheter Therapies for the Treatment of Valvular and Paravalvular Regurgitation in Acquired and Congenital Valvular Heart Disease

Publication Date

January 2015

Journal Title

Journal of the American College of Cardiology

Abstract

Transcatheter therapies in structural heart disease have evolved tremendously over the past 15 years. Since the introduction of the first balloon-expandable valves for stenotic lesions with implantation in the pulmonic position in 2000, treatment for valvular heart disease in the outflow position has become more refined, with newer-generation devices, alternative techniques, and novel access approaches. Recent efforts into the inflow position and regurgitant lesions, with transcatheter repair and replacement technologies, have expanded our potential to treat a broader, more heterogeneous patient population. The evolution of multimodality imaging has paralleled these developments. Three-and 4-dimensional visualization and concomitant use of novel technologies, such as fusion imaging, have supported technical growth, from pre-procedural planning and intraprocedural guidance, to assessment of acute results and follow-up. A multimodality approach has allowed operators to overcome many limitations of each modality and facilitated integration of a multidisciplinary team for treatment of this complex patient population. (C) 2015 by the American College of Cardiology Foundation.

Volume Number

66

Issue Number

2

Pages

169-183

Document Type

Article

EPub Date

2015/07/15

Facility

School of Medicine

Primary Department

Cardiology

PMID

WOS:000357418600010

DOI

10.1016/j.jacc.2015.05.034

This document is currently not available here.


Share

COinS